Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Queensland Health
Citi
Julphar
Baxter
Boehringer Ingelheim
Covington
Harvard Business School

Generated: May 25, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,572,909

« Back to Dashboard

Summary for Patent: 4,572,909
Title: 2-(Secondary aminoalkoxymethyl) dihydropyridine derivatives as anti-ischaemic and antihypertensive agents
Abstract:A dihydropyridine compound of the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof, wherein Y is --(CH.sub.2).sub.2 --, --(CH.sub.2).sub.3 --, --CH.sub.2 CH(CH.sub.3)-- or --CH.sub.2 C(CH.sub.3).sub.2 --; R is aryl or heteroaryl; R.sup.1 and R.sup.2 are each independently C.sub.1 -C.sub.4 alkyl or 2-methoxyethyl; and R.sup.3 is hydrogen, C.sub.1 -C.sub.4 alkyl, 2-(C.sub.1 -C.sub.4 alkoxy)ethyl, cyclopropylmethyl, benzyl, or --(CH.sub.2).sub.m COR.sup.4 where m is 1, 2 or 3 and R.sup.4 is hydroxy, C.sub.1 -C.sub.4 alkoxy or --NR.sup.5 R.sup.6 where R.sup.5 and R.sup.6 are each independently hydrogen or C.sub.1 -C.sub.4 alkyl can be employed for treating or preventing a heart condition or hypertension.
Inventor(s): Campbell; Simon F. (Deal, GB2), Cross; Peter E. (Canterbury, GB2), Stubbs; John K. (Deal, GB2)
Assignee: Pfizer Inc. (New York, NY)
Application Number:06/576,982
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,572,909
Patent Claims: 1. A dihydropyridine compound of the formula ##STR58## or a pharmaceutically acceptable acid addition salt thereof, wherein Y is --(CH.sub.2).sub.2 --, --(CH.sub.2).sub.3 --, --CH.sub.2 CH(CH3)-- or --CH.sub.2 C(CH.sub.3)2--;

R is aryl; R.sup.1 and R.sup.2 are each independently C.sub.1 -C.sub.4 alkyl or 2-methoxyethyl; and R.sup.3 is hydrogen, C.sub.1 -C.sub.4 alkyl, 2-(C.sub.1 -C.sub.4 alkoxy)ethyl, cyclopropylmethyl, benzyl, or --(CH.sub.2).sub.m COR.sup.4 where m is 1, 2 or 3 and R.sup.4 is hydroxy, C.sub.1 -C.sub.4 alkoxy or --NR.sup.5 R.sup.6 where R.sup.5 and R.sup.6 are each independently hydrogen or C.sub.1 -C.sub.4 alkyl; wherein aryl is phenyl; phenyl substituted by one or two of nitro, halo, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, hydroxy, trifluoromethyl or cyano; 1-naphthyl; or 2-naphthyl.

2. A compound according to claim 1 wherein the aryl is 2-chlorophenyl or 2,3-dichlorophenyl.

3. A compound according to claim 1 wherein R.sup.3 is H, CH.sub.3 or --(CH.sub.2).sub.m COR.sup.4 wherein m is 1.

4. A compound according to claim 1 wherein R.sup.1 is CH.sub.3.

5. A compound according to claim 1 wherein R.sup.2 is C.sub.2 H.sub.5.

6. A compound according to claim 1 wherein Y is --(CH.sub.2).sub.2 --.

7. A compound according to claim 1 wherein R is 2-chlorophenyl or 2,3-dichlorophenyl, R.sup.1 is CH.sub.3, R.sup.2 is C.sub.2 H.sub.5, Y is --(CH.sub.2).sub.2 -- and R.sup.3 is H or CH.sub.3.

8. A compound according to claim 7 wherein R is 2-chlorophenyl and R.sup.3 is H.

9. A compound according to claim 1 wherein R.sup.1 and R.sup.2 are each alkyl.

10. A compound according to claim 9 wherein Y is --(CH.sub.2).sub.2 --.

11. A compound according to claim 10 wherein R.sup.3 is hydrogen.

12. A compound according to claim 11 wherein R.sup.1 is ethyl, R.sup.2 is methyl and R is 2,3-dichlorophenyl.

13. A compound according to claim 11 wherein R.sup.1 is methyl, R.sup.2 is ethyl and R is 2-chloro-3-trifluoromethylphenyl.

14. A pharmaceutical composition comprising an anti-ischaemic or antihypertensive effective amount of a compound according to claim 1 and a pharmaceutically acceptable diluent or carrier.

15. A pharmaceutical composition comprising an anti-ischaemic or antihypertensive effective amount of a compound according to claim 7 and a pharmaceutically acceptable diluent or carrier.

16. A method of treating or preventing ischaemic heart disease in man which comprises administering an anti-ischaemic effective amount of a compound according to claim 1.

17. A method of treating or preventing hypertension in man which comprises administering an antihypertensive effective amount of a compound according to claim 1.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Argus Health
Dow
US Department of Justice
McKesson
Accenture
Merck
Johnson and Johnson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.